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G protein-coupled receptor (GPCR) heteromers are macro-
molecular complexes with unique functional properties differ-
ent from those of its individual protomers. Little is known about
what determines the quaternary structure of GPCR heteromers
resulting in their unique functional properties. In this study,
using resonance energy transfer techniques in experiments
with mutated receptors, we provide for the first time clear
evidence for a key role of intracellular domains in the deter-
mination of the quaternary structure of GPCR heteromers
between adenosine A2A, cannabinoid CB1, and dopamine D2
receptors. In these interactions, arginine-rich epitopes form
salt bridges with phosphorylated serine or threonine residues
fromCK1/2 consensus sites. Each receptor (A2A, CB1, and D2)
was found to include two evolutionarily conserved intracel-
lular domains to establish selective electrostatic interactions
with intracellular domains of the other two receptors, indi-
cating that these particular electrostatic interactions consti-
tute a general mechanism for receptor heteromerization.
Mutation experiments indicated that the interactions of
the intracellular domains of the CB1 receptor with A2A andD2
receptors are fundamental for the correct formation of the
quaternary structure needed for the function (MAPK signal-
ing) of the A2A-CB1-D2 receptor heteromers. Analysis of
MAPK signaling in striatal slices of CB1 receptor KOmice and
wild-type littermates supported the existence ofA1-CB1-D2 recep-
tor heteromer in the brain. These findings allowed us to propose
the firstmolecularmodel of the quaternary structure of a receptor
heteromultimer.
Receptor heteromers are the focus of intense research, as
through heteromerization receptors become unique functional
entities with different properties from those of either receptor
when not engaged in heteromerization resulting in new thera-
peutic targets (1–4). Their unique properties provide a “bio-
chemical fingerprint” thus allowing their identification in
native tissues (1, 3). There is already a long list of discovered
heteromers with two different G protein-coupled receptors
(GPCRs)2 (2, 4). Furthermore, we recently obtained evidence
for the existence of receptor heteromultimers, i.e. heteromers
including more than two different receptors, and reported on
heteromers, including the GPCRs adenosine A2A, cannabinoid
CB1, and dopamine D2 receptors, in transfected cells (5).
Evidence of GPCR homomultimers has also been recently
demonstrated in living cells (6, 7). Many important ques-
tions regarding receptor heteromers and heteromultimers
remain unanswered. What is the arrangement of their GPCR
units (quaternary structure)? What are the molecular deter-
minants of their quaternary structure? Last but not least,
what is their functional significance in native tissues?
It was inferred that different molecular mechanisms were
involved in GPCR homo- and heteromerization. For family C
GPCRs, disulfide bonds between extracellular domains as well
as coiled-coil interactions between C-terminal domains seem
to be necessary for the formation of functional homomeric or
heteromeric receptors (8). For oligomerization of family A
GPCRs, the helical transmembrane (TM) domains seem to be
particularly important (7, 9–15). In this study, by using
mutated A2A, CB1, and D2 receptors, we investigated the rele-
vance of electrostatic interactions (16) between intracellular
domains in the determination of the quaternary structure of
GPCR heteromers between A2A, CB1, and D2 receptors. Our
initial goal was to obtain evidence for multiple intracellular
interactions in the A2A-CB1-D2 receptor heteromultimer. Sig-
nificantly, the same intracellular domains involved in A2A-
CB1-D2 receptor heteromultimerization were also involved in
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A2A-D2, A2A-CB1, and CB1-D2 receptor heteromerization. A
three-dimensional model of the quaternary structure of the
receptor heteromultimer was obtained by using the informa-
tion from resonance energy transfer between A2A, CB1, and D2
receptors in the receptor heteromultimer. Furthermore, a bio-
chemical property of the receptor heteromultimerwas found to
be dependent on its correct quaternary structure, determined
by the intracellular electrostatic interactions, which allowed its
identification in rodent brain tissue.
EXPERIMENTAL PROCEDURES
Cell Culture—HEK-293T cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) (Invitrogen) supplemented
with 2 mM L-glutamine, 100 units/ml penicillin/streptomycin,
and 5% (v/v) heat-inactivated fetal bovine serum (FBS) (all sup-
plements were from Invitrogen). CHO cell lines were main-
tained in -minimal essential medium without nucleosides,
containing 10% fetal calf serum, 50 g/ml penicillin, 50 g/ml
streptomycin, and 2 mM L-glutamine (300 g/ml). Cells were
maintained at 37 °C in an atmosphere of 5% CO2 and were
passaged when they were 80–90% confluent, twice a week.
Mutant Receptors—Ser374 in the C-terminal domain of the
human A2A receptor was mutated to Ala to obtain the A2AA374
receptor. The sequence 199RIFLAARRQ207 (boldface letters
indicate the amino acid involved in the interaction between
the receptors and the residues that were mutated) in the cyto-
plasmat the end ofTM5of humanA2A receptorwasmutated to
199RIFLAAAAQ207 to obtain the A2AA205-A206 receptor. The
sequence 462SVSTDTSAE470 in the C-terminal domain of
human CB1 receptor was mutated to 462SVSTDAAAE470
to obtain the CB1A467-A468 receptor. The sequence
321TSEDGKVQVT330 in the third intracellular loop of human
CB1 receptor was mutated to 321AAEDGKVQVT330 to obtain
CB1A321-A322 receptor. Mutations were performed by site-di-
rected mutagenesis (Cellogenetics, Ijamsville, MD).
Fusion Proteins and Expression Vectors—The human cDNAs
of the A2A, CB1, and the mutant versions of these receptors or
the human D2, D2S, and D4.4 receptors, cloned in pcDNA3.1,
were amplified without their stop codons using sense and anti-
sense primers harboring unique EcoRI and BamHI sites to
clone A2A, A2AA374, andA2AA205-A206 receptors in theRluc cor-
responding vector, EcoRI and KpnI to clone D2 and D2S recep-
tors in the GFP2 corresponding vector, BamHI and EcoRI to
cloneCB1, CB1A467-A468, andCB1A321-A322 in the enhancedYFP
corresponding vector, and XhoI and BamHI sites to clone D4.4
receptor in the Rluc corresponding vector. The amplified frag-
mentswere subcloned to be in-frame into restriction sites of the
multiple cloning sites of pcDNA3.1-Rluc, pGFP2-N3(h),
pEYFP-N1 (Clontech) to give the plasmids corresponding to
A2A-Rluc, A2AA374-Rluc A2AA205-A206-Rluc, D4-Rluc, D2-GFP2,
D2S-GFP2, CB1-YFP, CB1A467-A468-YFP, and CB1A321-A322-YFP
receptor fusion proteins. The cDNA of the 5HT2B-YFP fusion
protein was kindly provided by Dr. Irma Nardi (University of
Pisa, Italy). Under these conditions, the fusion proteins are
expressed at the membrane level, are not strongly overex-
pressed, and are quantitatively expressed in similar amounts
(5).
Transient Transfection and Sample Preparation—HEK-
293T or CHO cells growing in 6-well dishes were transiently
transfectedwith the corresponding fusion protein cDNAby the
polyethyleneimine method (Sigma). Cells were incubated (4 h)
with the corresponding cDNA together with polyethylene-
imine (5.47 mM in nitrogen residues) and 150 mM NaCl in a
serum-starved medium. After 4 h, the medium was changed to
a fresh complete culturemedium. Forty eight hours after trans-
fection, cells were washed twice in quick succession in Hanks’
balanced salt solutionwith 10mMglucose, detached, and resus-
pended in the same buffer containing 1 mM EDTA. To control
the cell number, sample protein concentration was determined
using a Bradford assay kit (Bio-Rad) using bovine serum albu-
min dilutions as standards. Cell suspension (20 g of protein)
was distributed into 96-well microplates; black plates with
transparent bottom were used for FRET and fluorescence
determinations, and white plates with white bottom were used
for BRET and SRET experiments.
BRET Experiments—HEK-293T cells expressing the corre-
sponding donor (receptor Rluc) and increasing amounts of the
corresponding acceptor (receptor GFP2 for BRET2 or receptor
YFP for BRET1), as indicated in figure legends, were used.With
aliquots of transfected cells (20 g of protein), three different
determinations were performed in parallel. (i) To quantify fluo-
rescence proteins expression, cells were distributed in 96-well
microplates (black plates with transparent bottom), and fluo-
rescence was read in a Fluostar Optima Fluorimeter (BMG
Labtechnologies, Offenburg, Germany) equipped with a high
energy xenon flash lamp, using an excitation filter at 410 nm for
receptor GFP2 reading (BRET2) or 485 nm for receptor YFP
reading (BRET1), and emission was detected using filters at 510
nm (for GFP2) or 530 nm (for YFP). Receptor fluorescence
expressionwas determined as fluorescence of the sampleminus
the fluorescence of cells expressing receptor Rluc alone. (ii) For
BRET2 and BRET1 measurements, the equivalent of 20 g of
cell suspensionwas distributed in 96-wellmicroplates (Corning
3600, white plates with white bottom), and 5 M DeepBlueC
(BRET2) or coelenterazine H (BRET1) (Molecular Probes,
Eugene,OR)was added. For BRET2 experiments, readingswere
collected immediately (30 s) after addition of DeepBlueC
using aMithras LB 940 (Berthold Technologies, DLReady, Ger-
many) that allows the integration of the signals detected in the
short wavelength filter at 410 nm and the long wavelength filter
at 510 nm. In BRET1 after 1min of adding coelenterazineH, the
readings were collected using a Mithras LB 940 that allows the
integration of the signals detected in the short wavelength filter
at 485 nm and the long wavelength filter at 530 nm. (iii) To
quantify receptor Rluc expression, luminescence readings were
performed after 10 min of adding 5 M coelenterazine H. The
net BRET is defined as ((long wavelength emission)/(short
wavelength emission))  Cf, where Cf corresponds to ((long
wavelength emission)/(short wavelength emission)) for the
Rluc construct expressed alone in the same experiment.
FRET Experiments—HEK-293T cells expressing the corre-
sponding donor (receptor GFP2) and increasing amounts of the
corresponding acceptor (receptor YFP), as indicated in figure
legends, were used. Using aliquots of transfected cells (20 g of
protein), two different determinations were performed in par-
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allel. (i) To quantify YFP fluorescence, due to receptor YFP
expression, the same procedure as described for BRET experi-
ments was used. (ii) For FRETmeasurements, the equivalent of
20 g of cell suspension was distributed into 96-well micro-
plates (black plates with a transparent bottom) and read in a
Fluostar Optima fluorimeter equipped with a high energy
xenon flash lamp, using an excitation filter at 410 nm and an
emission filters at 510 nm (Chx) and 530 nm (Chy). Gain set-
tings were identical for all experiments to keep the relative con-
tribution of the fluorophores to the detection channels con-
stant for spectral unmixing. The contribution of GFP2 and YFP
proteins alone to the two detection channels (spectral signature
(17)) was measured in experiments with cells expressing only
one of these proteins and normalized to the sum of the signal
obtained in the two detection channels. The spectral signatures
of the different receptors fused to either GFP2 or YFP did not
vary significantly from the determined spectral signatures of
the fluorescent proteins alone. In determinations i and ii, linear
unmixing was done taking into account the spectral signature
as described by Zimmermann et al. (17) to separate the two
emission spectra. For quantitation of the fluorescence emitted
by each of two individual fluorophores (FluoA corresponding
to the donor and FluoB corresponding to the acceptor) in FRET
experiments, Equation 1 was applied,
FluoA  S/1 1/R
FluoB  S/1 R
Being (Eq. 1)
S  Chx Chy
R  ByQ  Bx/Ax  AyQ
Q  Chx/Chy
where Chx and Chy represent the signals in detection chan-
nels x and y, and Ax, Bx and Ay, Bx represent the normalized
contributions of FluoA or FluoB to channels x and y, as they
are known from the spectral signatures of the fluorescent
proteins.
Sequential Resonance Energy Transfer (SRET) Experiments—
The recently introduced sequential BRET-FRET (SRET) tech-
nique (5) not only allows the demonstration of heteromeriza-
tion of three proteins but can also provide information about
the quaternary structure of the heterotrimeric complex. By
transfecting three receptors separately fused to Rluc, GFP2, and
YFP, the detection of the SRET2 signal demonstrates the phys-
ical interactions between the three receptors. In SRET2, the
oxidation of the Rluc substrate DeepBlueC triggers GFP2 exci-
tation (BRET2), which triggers a subsequent excitation of
YFP (FRET) (see Fig. 1). Emission of YFP after addition of
DeepBlueC is only possible if the three fusion proteins are in
close proximity (10 nm), allowing bioluminescent and fluo-
rescent SRET to occur. For SRET experiments, HEK-293T cells
were transiently co-transfected with the indicated amounts of
plasmid cDNAs corresponding to receptor Rluc, receptor
GFP2, and receptor YFP (see figure legends). In the experiments
without casein kinase 1/2 inhibitors, cells were used 48 h post-
transfection. When using casein kinase 1/2 inhibitors, cells
were treated with casein kinase 1 inhibitor IC 261 (50 M; Cal-
biochem) and casein kinase 2 inhibitor TBAC (10 M; Calbio-
chem) 4 h after transfection, and after 24 h, the medium was
changed to a fresh complete culture medium containing the
same amount of inhibitors, and cells were used 48 h post-trans-
fection. Using aliquots of transfected cells (20 g of protein),
different determinations were performed in parallel. (i) Quan-
tification of protein-YFP expression was performed as indi-
cated in FRET experiments. The sample fluorescence is the
fluorescence calculated as described minus the fluorescence of
cells expressing only protein-Rluc and protein-GFP2. (ii) Quan-
tification of protein-Rluc expression was by determination of
the luminescence due to protein-Rluc. Cells were distributed in
96-well microplates (Corning 3600, white plates with white
bottom), and luminescence was determined 10 min after addi-
tion of 5 M coelenterazine H in a Mithras LB 940 multimode
reader. (iii) BRET and FRETwere combined to generate a tech-
nique called sequential BRET-FRET (SRET) that permits iden-
tification of heteromers formed by three different proteins.
Cells were distributed in 96-well microplates (Corning 3600,
white plates with white bottom), and 5 MDeepBlueC (Molec-
ular Probes, Eugene, OR) was added. The SRET2 signal was
collected using a Mithras LB 940 reader with detection filters
for short wavelength (410 nm) and long wavelength (530 nm).
By analogy with BRET, net SRET2 is defined as ((long wave-
length emission)/(short wavelength emission))  Cf, where Cf
corresponds to long wavelength emission/short wavelength
emission for cells expressing protein-Rluc and protein-GFP2.
Linear unmixing was done for SRET2 quantification, taking
into account the spectral signature to separate the two fluores-
cence emission spectra (17). (iv) Using aliquots of cells trans-
fected for SRET experiments, BRET1, BRET2, and FRET mea-
surements were performed as indicated above. A SRET2
saturation curve can be obtained determining SRET2 as a func-
tion of increasing expression of the FRET acceptor (receptor
YFP). From these saturation curves, an apparent SRETmax was
determined by fitting data to a monophasic saturation curve by
nonlinear regression using the commercial Grafit curve-fitting
software (Erithacus Software, Surrey, UK). These parameters
have a similar meaning to these parameters when applied to
BRET assays (5).
ERK Phosphorylation Assays—Wild-type littermates and
CB1 receptor knock-out CD1 albino Swiss male mice, 8 weeks
old, weighing 25 g were used. The generation of mice lacking
CB1 receptor has been described elsewhere (18, 19). Mice were
housed five per cage in a temperature- (21 1 °C) and humid-
ity-controlled (55 10%) room with a 12:12 h light/dark cycle
(light between 08:00 and 20:00 h) with food and water ad libi-
tum. Animal procedureswere conducted according to standard
ethical guidelines (European Communities Council Directive
86/609/EEC) and approved by the Local Ethical Committee
(IMAS-IMIM/UPF). Mice were decapitated with a guillotine,
and the brains were rapidly removed and placed in ice-cold
oxygenated (O2/CO2, 95:5%) Krebs-HCO3 buffer (124 mM
NaCl, 4 mM KCl, 1.25 mM NaH2PO4, 1.5 mM MgCl2, 1.5 mM
CaCl2, 10mMglucose, and 26mMNaHCO3, pH7.4). The brains
were sliced at 4 °C in a brain matrix (Zivic Instruments, Pitts-
burgh, PA) into 0.5-mm coronal slices. Slices were kept at 4 °C
in Krebs-HCO3 buffer during the dissection of the striatum.
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Each slice was transferred into an incubation tube containing 1
ml of ice-coldKrebs-HCO3 buffer. The temperaturewas raised
to 23 °C, and after 30 min, the media were replaced by 2 ml of
Krebs-HCO3 buffer (23 °C). The slices were incubated under
constant oxygenation (O2/CO2, 95:5%) at 30 °C for 4–5 h in an
Eppendorf thermomixer (Eppendorf-5 Prime, Inc., Boulder,
CO). The media were replaced by 200 l of fresh Krebs-HCO3
buffer, and after 30min, 1M of the A2A receptor agonist CGS-
21680, 1 M of the D2 receptor agonist quinpirole, or both pre-
pared in Krebs-HCO3 buffer were added. After 10 min, the
incubation solution was discarded, and slices were frozen on
dry ice and stored at 80 °C. When ERK phosphorylation
assays were performed in cell cultures, CHO cells (48 h after
transfection) were cultured in serum-free medium for 16 h
before the addition of any agent. Cells were resuspended in
Hanks’ balanced salt solution buffer and were treated for 5 min
with CGS2168 (200 nM), quinpirole (1M), or amixture of both
ligands and rinsed with ice-cold phosphate-buffered saline.
Both cells and slices were lysed by the addition of 500 l of
ice-cold lysis buffer (50 mM Tris-HCl, pH 7.4, 50 mM NaF, 150
mMNaCl, 45 mM -glycerophosphate, 1% Triton X-100, 20 M
phenylarsine oxide, 0.4mMNaVO4, andprotease inhibitormix-
ture). The cellular debris was removed by centrifugation at
13,000 g for 5 min at 4 °C, and the protein was quantified by
the bicinchoninic acid method using bovine serum albumin
dilutions as standard. To determine the level of ERK1/2 phos-
phorylation, equivalent amounts of protein (10 g) were sepa-
rated by electrophoresis on a denaturing 7.5% SDS-polyacryl-
amide gel and transferred onto PVDF membranes. The
membranes were then probed with a mouse anti-phospho-
ERK1/2 antibody (Sigma, 1:2500). To rule out that the differ-
ences observed were due to the application of unequal amounts
of lysates, PVDF blots were stripped and probed with a rabbit
anti-ERK1/2 antibody that recognizes both phosphorylated
and nonphosphorylated ERK1/2 (Sigma, 1:40,000). Bands were
visualized by the addition of anti-mouse HRP-conjugated
(Dako, Glostrup, Denmark) or anti-rabbit HRP-conjugated
(Sigma) secondary antibodies, respectively, and SuperSignal
West Pico chemiluminescent substrate (Pierce). Bands densi-
ties were quantified with LAS-3000 (Fujifilm), and the level of
phosphorylated ERK1/2 isoforms was normalized for differ-
ences in loading using the total ERK protein band intensities.
Quantitative analysis of detected bands was performed by
ImageGauge version 4.0 software. Bifactorial ANOVAandpost
hoc Bonferroni tests were used for statistical comparisons.
Mass Spectometric Analysis—0.3 l of equimolar solutions
of the various peptides were deposited on the sample plate fol-
lowed by 0.3 l of matrix, a saturated solution of 2,4,6-trihy-
droxyacetophenone in 50% ethanol, and left to dry at room
temperature. Spectra of each sample spot were acquired using a
MALDI TOF-TOF instrument (Applied Biosystem 4700 pro-
teomics analyzer, Framingham,MA) in positive ionmode. Each
spectrum is the average of 1000 shots. All peptideswere synthe-
sized at The Johns Hopkins School of Medicine “Synthesis and
Sequencing Facility.”
Computational Models of D2, CB1, and A2A Receptors—The
amino acid sequences of the human D2 receptor (accession
number P14416), CB1 receptor (P21554), and A2A receptor
(P29274) receptors were obtained from UniProt. Structural
simulations of the A2A receptor are based on its crystal struc-
ture (PDB code 3EML) (20). Simulations of the D2 and CB1
receptors are based on computational models constructed by
homology modeling techniques using the crystal structure of
the 2-adrenergic receptor (PDB code 2RH1) (21, 22) as tem-
plate. Because of the absence of P5.50 Ballesteros-Weinstein
numbering (23) in the CB1 receptor, we superimposed
Tyr292(5.58) and Lys300(5.66) to Tyr219(5.58) and Lys227(5.66)
of the 2-adrenergic receptor. Tyr5.58 and Lys5.66 are struc-
tural and functional amino acids involved in the stabilization of
the active state by interacting with Arg3.50 and Asp/Glu6.30,
respectively, as revealed by the recent crystal structure of the
ligand-free opsin, which contains several distinctive features of
the active state (24). The highly conserved NPXXYXn 5,6F(K/
R) motif at the junction between TM7 and Hx8 is one residue
shorter in the 2-adrenergic receptor (n 5) than in rhodopsin
and D2 or CB1 receptors (n  6). Thus, this junction in D2 or
CB1 receptors was modeled as in rhodopsin (PDB codes 1GZM
and 2Z73) (25, 26). The unambiguous assignment of the TM
boundaries to a particular position is not possible. However, we
have assumed that TM5ofA2A extends to positionArg206(5.67)
as shown in the crystal structure (20), andTM5ofD2 extends to
position Arg220(5.69) according to the 2-based homology
model (21, 22). These definitions of TM5 cause Arg205(5.66)–
Arg206(5.67) of the A2A receptor and 215(5.64)VLR-
RRRKRVN224 of the D2 receptor to be located at the end of
TM5 in the cytoplasm. In contrast, the Swiss Protein Database
assigns these epitopes of A2A and D2 in IL3. The crystal struc-
ture of squid rhodopsin (PDB code 2Z73) has shown that in
addition to the conserved amphipathicHx8 that runs parallel to
the membrane, the C terminus expands toward TM6 (25).
However, the structural homology, among GPCRs, probably
does not extend to this C-tail domain because of its high varia-
bility in length and amino acid composition among the mem-
bers of the family. This C-tail is formed by 59 amino acids in the
CB1 receptor (Ser414–Leu472), only 1 amino acid in the D2
receptor (Cys443), and 104 amino acids in the A2A receptor
(Arg309–Ser412). Nevertheless, Ser414–Asn437 of the CB1 recep-
tor and Arg309–Gly330 of the A2A receptor, forming part of this
C-tail sequence, were modeled, in an arbitrary manner, based
on the structure of squid rhodopsin.
Computational Models of Receptor Heteromers—Cysteine
cross-linking experiments have suggested that receptor oligo-
merization involves the surfaces of TM1, -4, and/or -5 (10, 12,
13). Thus, the structures of receptor heteromers were modeled
in such a manner that substituted cysteines at position 1.35
could be cross-linked (TM1–TM1) (13); or positions 4.41, 4.44,
4.48, 4.51, and 4.59 (TM4-TM4invago) (12); or positions 4.50,
4.54, and 4.58 (TM4-TM4ago) (12); or position 5.41 (TM5-
TM5) (12).
RESULTS
Quaternary Structure of the A2A-CB1-D2 Receptor Heteromer—
Anobvious initial question about receptor heteromersmade up
of three different receptors is whether each receptor interacts
with the other two or not, i.e. if they form a triangular or linear
arrangement. As in a prior report (5), we first demonstrated the
Quaternary Structure of Receptor Heteromers
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ability of A2A-Rluc, D2-GFP2, and CB1-YFP receptors to form
heteromers by determining the SRET saturation curve in trans-
fectedHEK-293Tcells (Fig. 1a). In the same experimental prep-
aration, we found significant BRET2 and FRET signals between
the A2A-Rluc-D2-GFP2 receptor pair and the D2-GFP2-CB1-
YFP receptor pair, respectively (Fig. 1b). Furthermore, we also
detected by BRET1 assays a positive transfer of energy between
A2A-Rluc and CB1-YFP receptors (Fig. 1b). These data and the
positive SRET signal (Fig. 1a) in cells co-expressing A2A-Rluc,
D2-GFP2, and CB1-YFP receptors suggest a triangular arrange-
ment between the three receptors (Fig. 1c). In fact, taking into
account the correlation between FRET efficiency and acceptor/
donor distances and that Rluc, GFP2, and YFP are fused to the
end of the C terminus of the receptors, the distance between
BRET donors and acceptors can be approximated (17). Consid-
ering the high FRET efficiency between D2-GFP2 and CB1-YFP
receptors (36  3%), the range of the distance between GFP2
and YFP in the heteromer is estimated to be 5.7–6.1 nm. Thus,
a linear arrangement of the three receptors could give a pos-
itive SRET signal but a very much reduced or even nonsig-
nificant BRET1 signal between A2A-Rluc and CB1-YFP
receptors, because there is a rapid dissipation of the energy
transfer (to the 6th power of the distance). Therefore,
assuming that the heterotrimer is the minimal unit, only a
triangular arrangement of monomers (Fig. 1c) would make
both SRET (Fig. 1a) and BRET1 (Fig. 1b) possible between
A2A-Rluc and CB1-YFP receptors.
Multiple Electrostatic Interactions in A2A-CB1-D2 Receptor
Heteromers—The amino acid sequence of the human CB1
receptor contains two highly conserved epitopes with two adja-
cent Thr and Ser residues (supplemental Table 1), which have a
high probability of CK1/2-dependent phosphorylation (Swiss
ProteinDatabase “Net Phos” program (27)). They are located in
the distal portion of the C terminus (CT) of the CB1 receptor
(Thr467 and Ser468) and in the middle portion of intracellular
loop (IL) 3 (Thr321 and Ser322). The initial working hypothesis
was that these CB1 receptor epitopes, with high probability of
phosphorylation, would be relevant in determining the quater-
nary structure of the A2A-CB1-D2 receptor heteromer, by
establishing electrostatic interactions with Arg-rich epitopes
located in the A2A and D2 receptors.
Electrostatic Interaction between Phosphorylated Thr467–
Ser468 in the C Terminus of the CB1 Receptor and Arg205(5.66)-
Arg206(5.67) in the Cytoplasm at the End of Transmembrane
Helix 5 of the A2A Receptor—We first looked at possible alter-
ations in heteromerization between CB1 and A2A and between
CB1 andD2 receptor in cells co-expressing amutant CB1 recep-
tor in which Thr467(CT) and Ser468(CT) were replaced by Ala
(CB1A467-A468 receptor). In cells co-expressing A2A-Rluc and
CB1A467-A468-YFP receptors, there was a reduction of BRET1
values when compared with those obtained with cells express-
ing A2A-Rluc and CB1-YFP (Fig. 2a). On the other hand, these
mutations did not modify the FRET values between D2-GFP2
and CB1A467-A468-YFP, when compared with cells expressing
D2-GFP2 and CB1-YFP (Fig. 2b). This mutated CB1 receptor
and all the mutant receptors described below were shown to be
well expressed at the membrane level (results not shown). Fur-
thermore, the fact that the mutated CB1 receptor selectively
FIGURE 1. A2A-CB1-D2 receptor heteromerization in living cells. Assays were
performed 48 h post-transfection in cells expressing A2A-Rluc receptor (1 g of
cDNA;100,000 luminescence units), D2-GFP
2 receptor (3 g of cDNA;6,000
fluorescence units), and increasing amounts of CB1-YFP receptor cDNA (8,000–
18,000 fluorescence units). In each sample fluorescence or luminescence was
measured before every experiment to confirm similar donor expressions while
monitoring the increased acceptor expression. a and b, aliquots of these cells
were used. a, net SRET2was obtained bymonitoring the YFP fluorescence emis-
sion after DeepBlueC addition, with subtraction of the value obtainedwith cells
expressing the sameamountofA2A-Rluc andD2-GFP
2 receptors. SRET saturation
curves (black) were obtained for the coupling of A2A-Rluc, D2-GFP
2, and CB1-YFP
receptors, although negligible and linear SRET was obtained in cells expressing
equivalent amounts of A2A-Rluc, D2-GFP
2, and 5HT2B-YFP receptors (green) or
D4-Rluc, A2A-GFP
2, and CB1-YFP receptors (red). SRET data are expressed as
means S.D. of 5–8different experiments grouped as a functionof the amount
of SRET acceptor. b, BRET1 was obtained by monitoring the YFP fluorescence
emission after coelenterazineH addition, with subtraction of the value obtained
with cells expressing the sameamountofA2A-Rluc receptor. BRET
2wasobtained
bymonitoring theemissionofGFP2 fluorescenceafterDeepBlueCaddition,with
subtractionof the value obtainedwith cells expressing the sameamount of A2A-
Rluc receptors. FRET was measured by monitoring the emission of YFP fluores-
cenceafterexcitationofGFP2at400nm.Dataareexpressedas themeanS.E.of
5–8 independent experiments performed in duplicate. Linear unmixing of the
emission signals was applied to BRET2 and FRET values (b) and for YFP quantifi-
cation in saturation curves (a). c, schematic representation of the putative trian-
gular quaternary structure of the A2A-CB1-D2 receptor heteromer. mBu, milli-
BRET unit.
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altered the RET signal when co-ex-
pressed with A2A but not with the
D2 receptors demonstrates that the
results cannot be explained by
changes in the membrane expres-
sion of the mutant receptor or its
putative partner. These results
therefore show that Thr467(CT) and
Ser468(CT) of the CB1 receptor are
involved in the molecular interac-
tion with the A2A receptor in the
A2A-CB1 receptor heteromer. The
existence of measurable BRET1 val-
ues in cells co-expressing A2A-Rluc
and CB1A467-A468-YFP receptors
indicate that the CB1A467-A468
receptor is still able to interact phys-
ically with theA2A receptor and that
other domains, most likely TM
domains (see Introduction). are also
involved in A2A-CB1 receptor het-
eromerization. This CT epitope of
the CB1 receptor was also able to
interact with theA2A receptor in the
A2A-CB1-D2 receptor heteromer, as
deduced from the low SRET values
obtained when CB1A467-A468-YFP
receptor was co-expressed with
A2A-Rluc and D2-GFP2 receptors
(Fig. 2c). Furthermore, in cells
expressing CB1A467-A468-YFP, A2A-
Rluc, and D2-GFP2 receptors, BRET1
values between A2A-Rluc and
CB1A467-A468-YFP receptors and
BRET2 values between A2A-Rluc
and D2-GFP2 receptors were
significantly reduced, and FRET
values between D2-GFP2 and
CB1A467-A468-YFP receptors were
increased relative to cells expressing
nonmutated receptors (Fig. 2d).
Because the bioluminescent or fluo-
rescent proteins are fused to the
CT of the receptors, these results
indicate that expression of
CB1A467-A468-YFP receptors induced
a modification of the quaternary
structure of the A2A-CB1-D2 het-
eromer,with separation of theCTof
CB1 and A2A receptors and A2A and
D2 receptors and approximation of
the CT of CB1 and D2 receptors.
We then looked for the presence
of adjacent Arg residues in intra-
cellular domains of the A2A re-
ceptor that could potentially
interact with the phosphorylated
Thr467(CT) and Ser468(CT) of CB1
FIGURE 2. A2A-CB1
A467-A468-D2 receptor heteromerization in living cells. Assays were performed 48 h post-
transfection incellsexpressing the following:a,A2A-Rluc receptor (1gofcDNA;100,000 luminescenceunits) and
increasing amounts of cDNA of the CB1-YFP or CB1
A467-A468-YFP receptors (8,000–18,000 fluorescence units);mBu,
milli-BRET unit. b,D2-GFP
2 (3g of the cDNA;6,000 fluorescence units) and increasing amounts of the cDNA for
CB1-YFP or CB1
A467-A468-YFP; c and d, A2A-Rluc receptor (1 g of cDNA; 100,000 luminescence units), D2-GFP
2
receptor (3 g of the cDNA;6,000 fluorescence units), and increasing amounts of cDNA of the CB1
A467-A468-YFP
receptor (8,000–18,000 fluorescence units). In each sample, fluorescence or luminescence was measured before
every experiment to confirm similar donor expressions while monitoring the increased acceptor expression.
a, BRET1 saturation curves for the A2A-Rluc-CB1-YFP receptor pair (squares) and for the A2A-Rluc-CB1
A467-A468-YFP
receptorpair (triangles)wereobtainedbymonitoringtheYFPfluorescenceemissionaftercoelenterazineHaddition,
with subtraction of the value obtained with cells expressing the same amount of A2A-Rluc receptor. Data are
expressed as means S.D. of five different experiments grouped as a function of the amount of BRET1 acceptor.
b, FRET saturation curves for the D2-GFP
2-CB1-YFP receptor pair (triangles) and for the D2-GFP
2- CB1
A467-A468-YFP
receptor pair (squares) were obtained by monitoring the YFP fluorescence emission at 530 nm after excitation of
GFP2 at 400 nm, with subtraction of the value obtained with cells expressing the same amount of donor protein.
Data are expressed as means S.D. of seven different experiments grouped as a function of the amount of FRET
acceptor. c, net SRET2wasobtainedbymonitoring theemissionofYFP fluorescenceafterDeepBlueCaddition,with
subtraction of the value obtainedwith cells expressing the same amount of A2A-Rluc and D2-GFP
2 receptors. SRET
saturationcurves (solid line)wereobtainedforthecouplingofA2A-Rluc,D2-GFP
2,andCB1
A467-A468-YFPreceptorsand
comparedwith thecurveobtained for thecouplingofA2A-Rluc, D2-GFP
2, andCB1-YFP receptors (dotted line, seeFig.
1). SRET data are expressed as means S.D. of five different experiments grouped as a function of the amount of
SRET acceptor. d, BRET1, BRET2, and FRET were measured as indicated in Fig. 1 legend. Data are expressed as % of
valuesobtained in cells expressingA2A-Rluc, D2-GFP
2, andCB1-YFP receptors (control, Fig. 1b), inmeanS.E. of five
independentexperimentsperformed induplicate.One-wayANOVAfollowedbyBonferroni test showedsignificant
increases or decreases with respect to the control (*, p 0.05; **, p 0.01; ***, p 0.005). Linear unmixing of the
emission signalswasapplied to thedata forBRET2 andFRETvalues (bandd) and forYFPquantification in saturation
curves (a and c). e, the spectrum of a mixture of the following three peptides SVSTDAAAE, SVSTDpTpSAE, and
LRIFLAARR, shows only one noncovalent complex between SVSTDpTpSAE and LRIFLAARR at 2171.7 atomicmass
units (see text).
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receptor via electrostatic interac-
tions. We found a highly conserved
motif, Arg205(5.66)–Arg206(5.67)
(supplemental Table 1), located in
the cytoplasm at the end of TM5,
according to the crystal structure
(see “Experimental Procedures”).
Mass spectrometric analysis dem-
onstrated that a synthetic peptide
corresponding to this A2A receptor
epitope, 198LRIFLAARR206, and a
phosphorylated peptide corre-
sponding to the CT of the CB1
receptor epitope, 462SVSTDpTp-
SAE470, form stable noncovalent
complexes, and the Ala-containing
peptides LRIFLAAAA and SVST-
DAAAEdo not (Figs. 2e and 3e).We
then investigated whether the A2A
receptor epitope containing adja-
cent Arg could be involved in A2A-
CB1 receptor heteromerization by
using a mutant A2A receptor in
which Arg205(5.66)–Arg206(5.67)
were replaced by Ala (A2AA205-A206
receptor). Cells co-expressing
A2AA205-A206-Rluc and CB1-YFP
receptors showed lower BRET1 val-
ues than those expressing WT
receptors (Fig. 3a). On the other
hand, the BRET1 values between
A2AA205-A206-Rluc and D2-YFP
receptors were similar to the values
between A2A-Rluc and D2-YFP
receptors (Fig. 3b). Hence, the qua-
ternary structure of the A2A-CB1
receptor heteromer depends on an
electrostatic interaction between
epitopes located in the CT of the
CB1 receptor and in the cytoplasm
at the end of TM5 of the A2A recep-
tor. Furthermore, this electrostatic
interaction is also involved in A2A-
CB1-D2 receptor heteromerization
(Fig. 3, c and d). In fact, low SRET
values were obtained when the
A2AA205-A206-Rluc receptor was
co-transfected with D2-GFP2 and
CB1-YFP receptors (Fig. 3c). In cells
co-expressing A2AA205-A206-Rluc,
D2-GFP2, and CB1-YFP receptors,
BRET1 and BRET2 between the het-
eromer partners were significantly
reduced, and FRET values between
D2-GFP2 and CB1-YFP receptors
were increased, compared with
cells co-expressing nonmutated
receptors (Fig. 3d). Significantly,
FIGURE 3. A2A
A205-A206-CB1-D2 receptor heteromerization in living cells. Assays were performed 48 h post-
transfection in cells expressing the following:a,A2A-RlucorA2A
A205-A206-Rluc receptors (1 or 0.8gof cDNA respec-
tively;100,000 luminescence units) and increasing amounts of the cDNA of the CB1-YFP receptor (8,000–18,000
fluorescenceunits).mBu,milli-BRETunit.b,A2A-RlucorA2A
A205-A206-Rluc (1or0.8gofcDNA, respectively;100,000
luminescence units) and increasing amounts of the cDNA for D2-YFP. c and d, A2A
A205-A206-Rluc receptor (1 g of
cDNA;100,000 luminescenceunits),D2-GFP
2 receptor (3gof thecDNA;6,000 fluorescenceunits), and increas-
ing amounts of cDNA of the CB1-YFP receptor (8,000–18,000 fluorescence units). In each sample fluorescence or
luminescence was measured before every experiment to confirm similar donor expressions while monitoring the
increased acceptor expression. a, BRET1 saturation curves for the A2A-Rluc-CB1-YFP receptor pairs (squares) and for
theA2A
A205-A206-Rluc-CB1-YFP receptor pair (triangles) were obtainedbymonitoring the YFP fluorescence emission
after coelenterazine H addition, with subtraction of the value obtained with cells expressing the same amount of
donor. Data are expressed as means S.D. of five different experiments grouped as a function of the amount of
BRET1 acceptor.b, BRET1 saturationcurves for theA2A-Rluc-D2-YFP receptorpairs (triangles) and for theA2A
A205-A206-
Rluc-D2-YFP receptor pair (squares) were obtained by monitoring the YFP fluorescence emission after coelentera-
zine H addition, with subtraction of the value obtained with cells expressing the same amount of donor. Data are
expressed as means S.D. of five different experiments grouped as a function of the amount of BRET1 acceptor.
c, net SRET2wasobtainedbymonitoring theYFP fluorescenceemissionafterDeepBlueCaddition,with subtraction
of the value obtained with cells expressing the same amount of A2A
A205-A206-Rluc and D2-GFP
2 receptors. SRET
saturationcurves (solid line)wereobtained for thecouplingofA2A
A205-A206Rluc,D2-GFP
2, andCB1-YFP receptorsand
compared with the curve obtained for the coupling of A2A-Rluc, D2R-GFP
2, and CB1-YFP receptors (dotted line, see
Fig. 1). SRET data are expressed asmeans S.D. of five different experiments grouped as a function of the amount
of SRET acceptor.d,BRET1, BRET2, andFRETweremeasuredas indicated in Fig. 1 legend.Data are expressedas%of
values obtained in cells expressingA2A-Rluc, D2-GFP
2, andCB1-YFP receptors (control, Fig. 1b), inmean S.E. of five
independentexperimentsperformed induplicate.One-wayANOVAfollowedbyBonferroni test showedsignificant
increases or decreases with respect to the control (**, p 0.01; ***, p 0.005). Linear unmixing of the emission
signals was applied to the data for BRET2 and FRET values (d) and for YFP quantification in saturation curves (a–c).
e, spectrum of a mixture of the following three peptides LRIFLAAAA, LRIFLAARR, and SVSTDpTpSAE, shows only
oneNCX between SVSTDpTpSAE and LRIFLAARR at 2171.7 atomicmass units (see text).
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this outcome is qualitatively the
same as the one shown in Fig. 2d
with CB1A467-A468-YFP receptor,
as it would be expected if both
mutants disrupt the same inter-
molecular interaction.
Electrostatic Interaction between
Phosphorylated Thr321–Ser322 in
Intracellular Loop 3 of the CB1
Receptor and an Arg-rich Epitope in
Intracellular Loop 3 of the D2
Receptor—Because the Thr467(CT)-
Ser468(CT)-containing epitope of
theCB1 receptorwas found to inter-
act with Arg205(5.66)–Arg206(5.67)
of the A2A receptor, it was expected
that Thr321(IL3)–Ser322(IL3) of the
CB1 receptor could interact with the
D2 receptor. In fact, when co-ex-
pressing the mutant CB1A321-A322-
YFP and D2-Rluc receptors, the
BRET1 energy transfer between
Rluc and YFP was reduced when
compared with BRET1 values
obtained with CB1-YFP and
D2-Rluc receptors (Fig. 4a). On the
other hand, the BRET1 values
obtained in cells expressing
CB1A321-A322-YFP and A2A-Rluc
receptors were similar to those
obtained with cells expressing CB1-
YFP and A2A-Rluc (Fig. 4b). These
results therefore show that the
Thr321(IL3)–Ser322(IL3) motif of
the CB1 receptor is selectively
involved in the intermolecular
interactions with the D2 receptor in
the CB1-D2 receptor heteromer.
The fact that BRET1 is still measur-
able between CB1A321-A322-YFP and
D2-Rluc receptors indicates that,
once more, other epitopes are also
involved inCB1-D2 receptor hetero-
merization. Also, the same
Thr321(IL3)–Ser322(IL3) epitope of
theCB1 receptor interactedwith the
D2 receptor in the A2A-CB1-D2
receptor heteromer. Compared
with nonmutated receptors, co-
expression of CB1A321-A322-YFP
receptor with A2A-Rluc and
D2-GFP2 receptors showed a reduc-
tion in SRET values (Fig. 4c), and
FRET values were significantly
decreased, and BRET2 values were
increased, whereas BRET1 values
were not modified (Fig. 4d). This
suggests that replacement of
FIGURE 4. A2A-CB1
A321-A322-D2 receptor heteromerization in living cells. Assays were performed 48 h post-
transfection in cells expressing the following:a,D2-Rluc receptor (1gof cDNA;100,000 luminescenceunits) and
increasingamountsof thecDNAforCB1-YFPorCB1
A321-A322-YFPreceptors (8,000–18,000fluorescenceunits);b,A2A-
Rluc (1 g of cDNA; 100,000 luminescence units) and increasing amounts of the cDNA for CB1-YFP or
CB1
A321-A322-YFP;candd,A2A-Rluc receptor (1gofcDNA;100,000 luminescenceunits),D2-GFP
2 receptor (3gof
the cDNA;6,000 fluorescence units), and increasing amounts of cDNA of the CB1
A321-A322-YFP receptor (8,000–
18,000 fluorescenceunits). Ineachsample fluorescenceor luminescencewasmeasuredbeforeeveryexperiment to
confirm similar donor expressions while monitoring the increased acceptor expression. a, BRET1 saturation curves
for the D2-Rluc-CB1-YFP receptor pair (squares) and for D2-Rluc-CB1
A321-A322-YFP receptor pair (triangles) were
obtainedbymonitoringtheYFPfluorescenceemissionaftercoelenterazineHaddition,withsubtractionofthevalue
obtained with cells expressing the same amount of A2A-Rluc receptor. Data are expressed as means S.D. of six
different experiments grouped as a function of the amount of BRET1 acceptor. b, BRET1 saturation curves for the
A2A-Rluc-CB1-YFPreceptorpair (triangles)andforA2A-Rluc-CB1
A321-A322-YFPreceptorpair (squares)wereobtainedby
monitoring the YFP fluorescence emission after coelenterazine H addition, with subtraction of the value obtained
with cells expressing the same amount of A2A-Rluc receptor. Data are expressed as means S.D. of six different
experiments grouped as a function of the amount of BRET1 acceptor. c, net SRET2 was obtained bymonitoring the
YFP fluorescence emission after DeepBlueC addition, with subtraction of the value obtained with cells expressing
the same amount of A2A-Rluc and D2-GFP
2 receptors. SRET saturation curves (solid line) were obtained for the cou-
pling of A2A-Rluc, D2-GFP
2, andCB1
A321-A322-YFP receptors and comparedwith the curve obtained for the coupling
of A2A-Rluc, D2-GFP
2, and CB1-YFP receptors (dotted line, see Fig. 1). SRET data are expressed asmeans S.D. of six
different experiments grouped as a function of the amount of SRET acceptor. d, BRET1, BRET2, and FRET were
measured as indicated in Fig. 1b legend. Data are expressed as percent of values obtained in cells expressing
A2A-Rluc, D2-GFP
2, and CB1-YFP receptors (control, Fig. 1b), in mean  S.E. of six independent experiments per-
formed in duplicate. One-way ANOVA followed by Bonferroni test showed significant increases or decreases with
respect to the control (*, p 0.05; **, p 0.01). Linear unmixing of the emission signals was applied to the data for
BRET2 and FRET values (d) and for YFP quantification in saturation curves (a–c). e, the spectrum of amixture of the
following three peptides AAEDGKVQVT, pTpSEDGKVQVT, and VLRRRRKRVN shows only one NCX between
pTpSEDGKVQVT and VLRRRRKRVN at 2575.6 atomicmass units (see text).mBu, milli-BRET unit.
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Thr321(IL3) and Ser322(IL3) by Ala
in CB1 receptor induces a modifi-
cation of the quaternary structure
of the A2A-CB1-D2 receptor het-
eromer with separation of the CT
of the CB1 and D2 receptors and an
approximation of the CT of the
D2 and A2A receptors. Thus, CB1
receptor uses two different CK1/
2-dependent phosphorylatable
epitopes, located in their CT
(Thr467–Ser468) and IL3 (Thr321–
Ser322) domains, to establish
simultaneous electrostatic inter-
actions with the A2A and D2 recep-
tors, respectively, in the A2A-
CB1-D2 receptor heteromer.
Next step was finding out which
intracellular epitope of the D2 recep-
tor is involved in CB1-D2 receptor
heteromerization. D2 receptor con-
tains two highly conserved Arg-rich
epitopes (supplemental Table 1),
215(5.64)VLRRRRKRVN224, located
at the end of TM5 in the cytoplasm
(according to the homology mod-
eling using the 2-adrenergic
receptor as a template; see under
“Experimental Procedures”), and
266NRRRVEAARR275, in the mid-
dle of IL3. Because the VLR-
RRRKRVN epitope is most proba-
bly involved in A2A-D2 receptor
heteromerization (28, 29), we
explored the possibility that IL3 of
the D2 receptor could interact with
IL3 of the CB1 receptor (phos-
phorylated Thr321–Ser322), The D2
short isoform (D2S), an alternative
splicing that lacks 29 amino acid
residues of IL3 (30), including
266NRRRVEAARR275, was used.
SRET values were clearly reduced
whenD2S-GFP2 receptorwas co-ex-
pressed with A2A-Rluc and CB1-
YFP receptors (Fig. 5c). Signifi-
cantly, the D2S receptor led to the
same qualitative modifications of
the quaternary structure of the A2A-
CB1-D2 receptor heteromer as
those induced by CB1A321-A322-YFP
receptor (Fig. 5d). Thus, in cells
expressing A2A-Rluc, CB1-YFP, and
D2S-GFP2 receptors, FRET values
between D2S-GFP2 and CB1-YFP
receptors were significantly de-
creased, whereas BRET2 values
between A2A-Rluc and D2S-GFP2
FIGURE 5. A2A-CB1-D2S receptor heteromerization in living cells. Assays were performed 48 h post-trans-
fection in cells expressing the following: a, D2S-GFP
2 receptor (1.5 g of cDNA;5,000 fluorescence units) or
D2-GFP
2 receptor (2 g of cDNA; 5,000 luminescence units), and increasing amounts of cDNA of CB1-YFP
receptor (8,000–18,000 fluorescence units); b, A2A-Rluc (1 g of cDNA; 100,000 luminescence units) and
increasing amounts of cDNA for D2-GFP
2 or D2S-GFP
2; c and d, A2A-Rluc receptor (1 g of cDNA; 100,000
luminescence units), D2S-GFP
2 receptor (3gof the cDNA;6,000 fluorescence units) and increasing amounts
of the cDNA for CB1-YFP receptor (8,000–18,000 fluorescence units). mBu, milli-BRET unit. In each sample
fluorescence or luminescence was measured before every experiment to confirm similar donor expressions
whilemonitoring the increased acceptor expression. a, FRET saturation curves for the D2-GFP
2-CB1-YFP recep-
tor pair (squares) and for D2S-GFP
2-CB1-YFP receptor pair (triangles) were obtained by monitoring the YFP
fluorescenceemission at 530nmafter excitationofGFP2 at 400nm,with subtractionof the valueobtainedwith
cells expressing the same amount of donor protein. Data are expressed as means  S.D. of seven different
experiments grouped as a functionof the amount of FRET acceptor.b, BRET2 saturation curves for theA2A-Rluc-
D2-GFP
2 receptor pair (triangles) and for A2A-Rluc-D2S-GFP
2 receptor pair (squares) were obtained by monitor-
ing the YFP fluorescence emission after DeepBlueC addition, with subtraction of the value obtained with cells
expressing the same amount of A2A-Rluc receptor. Data are expressed as means S.D. of six different experi-
mentsgroupedas a functionof theamountof BRET2 acceptor. c, net SRET2wasobtainedbymonitoring theYFP
fluorescence emission after DeepBlueC addition, with subtraction of the value obtained with cells expressing
the same amount of A2A-Rluc and D2S-GFP
2 receptors. SRET saturation curves (solid line) were obtained for the
coupling of A2A-Rluc, D2S-GFP
2, andCB1-YFP receptors and comparedwith the curve obtained for the coupling
of A2A-Rluc, D2-GFP
2, and CB1-YFP receptors (dotted line, see Fig. 1). SRET data are expressed asmeans S.D. of
five different experiments grouped as a function of the amount of SRET acceptor. d, BRET1, BRET2, and FRET
were measured as indicated in Fig. 1 legend. Data are expressed as % of values obtained in cells expressing
A2ARluc, D2-GFP
2, and CB1-YFP receptors (control, Fig. 1b), in mean  S.E. of five independent experiments
performed in duplicate. One-way ANOVA followed by Bonferroni test showed significant increases or
decreases with respect to the control (***, p 0.005). Linear unmixing of the emission signals was applied to
the data for BRET2 and FRET values (a, b, and d) and for YFP quantification in saturation curves (a and c).
e, spectrum of a mixture of the following three peptides AAEDGKVQVT, pTpSEDGKVQVT, and NRRRVEAARR,
shows only one NCX between pTpSEDGKVQVT and NRRRVEAARR at 2506.8 atomic mass units (see text).
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receptors were increased, and
BRET1 values between A2A-Rluc
and CB1-YFP receptors were not
modified, when comparedwith cells
co-expressing A2A-Rluc, D2-GFP2,
and CB1-YFP receptors (Fig. 5d).
These results indicate that in the
A2A-CB1-D2 receptor heteromer,
CB1 receptors interactwith theArg-
rich domain located in IL3 of the D2
receptor.
Notably, expression of D2S-GFP2
or D2-GFP2 receptors with either
CB1-YFP or A2A-Rluc or receptors
gives similar FRET (Fig. 5a) or
BRET2 (Fig. 5b) values, respectively.
This indicates that in the absence of
the 266NRRRVEAARR275 epitope
in D2S-GFP2, the CB1 receptor can
potentially interact with the other
Arg-rich domain, 215(5.64)VLR-
RRRKRVN224, present in both iso-
forms of the D2 receptor. As
expected, mass spectrometric anal-
ysis demonstrated that a synthetic
peptide of the epitope located
in IL3 of the CB1 receptor
(321pTpSEDGKVQVT330), but not
its equivalent Ala-containing pep-
tide (AAEDGKVQVT), formed
stable noncovalent complexes
with the two Arg-rich epitopes of
the D2 receptor (215(5.64)VLR-
RRRKRVN224 and 266NRRRVEA-
ARR275) (Figs. 4e and 5e).
Electrostatic Interaction between
Phosphorylated Ser374 in the C Ter-
minus of the A2A Receptor and an
Arg-rich Domain in the Cytoplasm
at the End of Transmembrane
Helix 5 of the D2 Receptor—The
215(5.64)VLRRRRKRVN224 epitope
of the D2 receptor was shown to
be involved in A2A-D2 receptor het-
eromerization by interacting with
the CT domain of the A2A receptor
(19, 20). We found a dramatic
reduction of BRET1 values in cells
co-expressing a mutant A2A-Rluc
receptor, in which Ser374(CT) was
replaced by Ala (A2AA374-Rluc
receptor), and D2-YFP receptor
(Fig. 6a). On the other hand, co-ex-
pression of A2AA374-Rluc and CB1-
YFP receptors gave similar BRET1
values than WT receptors (Fig. 6b).
These results confirm that
Ser374(CT) of the A2A receptor is
FIGURE 6. A2A
A374-CB1-D2 receptor heteromerization in living cells. Assays were performed 48 h post-
transfection in cells expressing the following: a,A2A-Rluc or A2A
A374-Rluc receptors (1 or 0.8g of cDNA respec-
tively;100,000 luminescence units) and increasing amounts of cDNA of the D2-YFP receptor (8,000–18,000
fluorescenceunits);b,A2A-RlucorA2A
A374-Rluc (1 or 0.8gof cDNA respectively;100,000 luminescenceunits)
and increasing amounts of the cDNA for CB1R-YFP; c and d, A2A
A374-Rluc receptor (1 g of cDNA; 100,000
luminescence units), D2-GFP
2 receptor (3g of the cDNA;6,000 fluorescence units), and increasing amounts
of cDNA of CB1-YFP receptor (8,000–18,000 fluorescence units). In each sample fluorescence or luminescence
was measured before every experiment to confirm similar donor expressions while monitoring the increased
acceptor expression. a, BRET1 saturation curves for the A2A-Rluc-D2-YFP receptor pair (squares) and for the
A2A
A374-Rluc-D2-YFP receptor pair (triangles) were obtained bymonitoring the YFP fluorescence emission after
coelenterazine H addition, with subtraction of the value obtained with cells expressing the same amount of
donor. Data are expressed as means S.D. of five different experiments grouped as a function of the amount
of BRET1 acceptor. b, BRET1 saturation curves for the A2A-Rluc-CB1-YFP receptor pair (triangles) and for the
A2A
A374-Rluc-CB1-YFP receptor pair (squares) were obtained bymonitoring the YFP fluorescence emission after
coelenterazine H addition, with subtraction of the value obtained with cells expressing the same amount of
donor. Data are expressed as means S.D. of five different experiments grouped as a function of the amount
of BRET1 acceptor. c, net SRET2 was obtained by monitoring the YFP fluorescence emission after DeepBlueC
addition, with subtraction of the value obtained with cells expressing the same amount of A2A
A374-Rluc and
D2-GFP
2 receptors. SRET saturation curves (solid line) were obtained for the coupling of A2A
A374-Rluc, D2-GFP
2,
and CB1-YFP receptors and compared with the curve obtained for the coupling of A2A-Rluc, D2-GFP
2, and
CB1-YFP receptors (dotted line, see Fig. 1). SRET data are expressed asmean S.D. of five different experiments
grouped as a function of the amount of SRET acceptor. d, BRET1, BRET2, and FRET were measured as indicated
in Fig. 1 legend. Data are expressed as % of values obtained in cells expressing A2A-Rluc, D2-GFP
2, and CB1-YFP
(control, Fig. 1b) in mean  S.E. of five independent experiments performed in duplicate. One-way ANOVA
followed by Bonferroni test showed significant increases or decreases with respect to the control (*, p 0.05;
**, p 0.01; ***, p 0.005). Linear unmixing of the emission signalswas applied to the data for BRET2 and FRET
values (e) and for YFP quantification in saturation curves (a and b). e, spectrum of a mixture of the following
three peptides SAQEAQGNT, SAQEpSQGNT, and VLRRRRKRVN shows only one NCX between SAQEpSQGNT
and VLRRRRKRVN at 2353.6 atomic mass units (see text).mBu, milli-BRET unit.
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involved in themolecular interaction with the D2 receptor. Not
surprisingly, Ser374(CT) of the A2A receptor was also found to
be involved in providing the quaternary structure of the A2A-
CB1-D2 receptor heteromer. Low SRET values were obtained
when A2AA374-Rluc was co-expressed with D2-GFP2 and CB1-
YFP receptors (Fig. 6c), compared with cells co-expressing the
nonmutated receptors. From the analysis of BRET1, BRET2,
and FRET occurring between partners in cells expressing
A2AA374-Rluc, CB1-YFP, and D2-GFP2 receptors, it was
observed that BRET2 values were significantly reduced, but
FRET and BRET1 values were not significantly modified (Fig.
6d). These results indicate that the CT-mutated A2A recep-
tor induces a modification of the quaternary structure of the
A2A-CB1-D2 receptor heteromer, with separation of the CT
of the A2A and D2 receptors. Therefore, the A2A receptor
uses a double-Arg motif (Arg205(5.66)–Arg206(5.67)) located
in the cytoplasm at the end of transmembrane helix 5 and a
CK1/2-dependent phosphorylatable epitope located in CT
(Ser374) to establish selective electrostatic interactions with
the CB1 and D2 receptors, respectively. Hence, mass spectro-
metric analysis of a mixture of peptides corresponding to
the cytoplasmic epitope at the end of TM5 of the D2
(215(5.64)VLRRRRKRVN224) and the CT epitopes of the A2A
receptor (370SAQEpSQGNT378) and the mutant A2A recep-
tor (370SAQEAQGNT378) resulted in noncovalent com-
plexes between the D2 and the A2A receptor epitopes, but not
in the case of the mutant A2A receptor (Fig. 6e).
Role of Casein Kinase 1/2-mediated Phosphorylation in the
Quaternary Structure of A2A-CB1-D2 Receptor Heteromer—To
demonstrate the actual involvement of casein kinase-induced
phosphorylation in the electrostatic interactions between
A2A, CB1, and D2 receptors in the A2A-CB1-D2 receptor het-
eromer, we studied the effects of co-administration of casein
kinase 1 inhibitor IC 261 and casein kinase 2 inhibitor TBAC
on SRET saturation experiments in HEK-293T cells
co-transfected with A2A-Rluc, D2-GFP2, and CB1-YFP recep-
tors. As expected, the casein kinase inhibitors significantly
decreased SRET values (Fig. 7), supporting a role of casein
kinases on maintaining a phosphorylated state of the intra-
cellular domains of A2A and CB1 receptors involved in A2A-
CB1-D2 receptor heteromerization.
Computational Model of the Quaternary Structure of the
A2A-CB1-D2 Receptor Heteromer—Biochemical and biophysi-
cal studies have suggested that oligomerization of class A
GPCRs primarily involves TM1, -4, and/or -5 (7, 9–15). Thus,
the structure of the A2A-CB1-D2 receptor heteromer was mod-
eled using the following dimeric interfaces: TM1-TM1, TM4-
TM4invago, TM4-TM4ago, and TM5-TM5 (see under “Experi-
mental Procedures”). TM4-TM4invago and TM4-TM4ago stand
for the proposed rearrangement of the oligomerization inter-
face that has been observed for the dopamine D2 receptor upon
inverse agonist and agonist binding, respectively (12).
Modeling the CB1-D2 Receptor Heteromer—Initially, to dis-
cern which of these TM interfaces most favorably permits the
proposed electrostatic interaction between phosphorylated
Thr321(IL3)–Ser322(IL3) of CB1 and 266NRRRVEAARR275(IL3)
of D2 in the CB1-D2 receptor heteromer, all possible dimeric
interfaces were constructed (supplemental Fig. 1). It is impor-
tant to acknowledge the difficulty ofmodeling IL3 of either CB1
or D2 receptors unambiguously (see under “Experimental Pro-
cedures”); thus, the exact location of these epitopes in IL3 can-
not be determined. Nevertheless, it seems clear to us that the
TM1-TM1, TM4-TM4invago, and TM4-TM4ago interfaces
position IL3 of CB1 and D2 receptors in opposite sides of the
TM bundles (supplemental Fig. 1, a–c), which makes the pro-
posed electrostatic interaction difficult. In contrast, the TM5-
TM5 interface places IL3 of the CB1 receptor contiguous to
IL3 of the D2 receptor (supplemental Fig. 1d), facilitating
their electrostatic interaction. It thus seems reasonable to
propose that the Arg-rich epitope of the D2 receptor located
in the cytoplasm at the end of TM5 is involved in CB1-D2
receptor heteromerization.
Modeling the A2A-CB1 Receptor Heteromer—The A2A-CB1
receptor heteromer was also modeled through the entire set of
TM interfaces (supplemental Fig. 2) to reproduce the electro-
static interaction between phosphorylatedThr467–Ser468 in the
CT of the CB1 receptor and Arg205(5.66)–Arg206(5.67) in the
cytoplasm at the end of TM5 of theA2A receptor. CT of the CB1
receptor is made of 59 amino acids (Ser414–Leu472), in addition
to the conserved Hx8 that runs parallel to the membrane
(Ser401–Pro413). It is thus difficult to determine with precision
the position of Thr467(CT)–Ser468(CT). However, although
GPCRs CT vary greatly in length and sequence, we have
assumed that the CT of CB1 unfolds toward TM6 as found in
the crystal structure of squid rhodopsin (22). Taking these facts
into account, TM4-TM4invago, TM4-TM4ago, and TM5-TM5
interfaces betweenCB1 andA2A receptorswould allow the elec-
trostatic interaction between Thr467(CT)–Ser468(CT) and
Arg205(5.66)–Arg206(5.67) in the A2A receptor (supplemental
Fig. 2, b–d), whereas the TM1-TM1 interface would not
(supplemental Fig. 2a).
FIGURE 7. A2A-CB1-D2 receptor heteromerization in living cells treated
with casein kinase 1/2 inhibitors. SRET2 saturation experiments were per-
formed 48 h post-transfection in cells expressing A2A-Rluc receptor (1 g of
cDNA), D2-GFP
2 receptor (3 g of cDNA),and increasing amounts of CB1-YFP
receptor cDNA, treated with the casein kinase 1 inhibitor IC 261 (50 M) and
casein kinase 2 inhibitor TBAC (10M) as described under “Experimental Pro-
cedures.” In each sample fluorescence or luminescencewasmeasuredbefore
every experiment to confirm similar donor expressions (100,000 lumines-
cence units) and similar GFP2 fluorescence (6,000 fluorescence units) while
monitoring the increased acceptor expression (8,000–18,000 YFP fluores-
cence units). Net SRET2was obtained bymonitoring the emission of YFP fluo-
rescence after DeepBlueC addition, with subtraction of the value obtained
with cells expressing the same amount of receptor Rluc and receptor GFP2.
SRET2 saturation curves (solid lines) were compared with the curve obtained
for the coupling of A2A-Rluc, D2-GFP
2, and CB1-YFP receptors in cells not
treated with casein kinase inhibitors (dotted line, see Fig. 1). SRET data are
expressed as means S.D. of five different experiments grouped as a func-
tion of the amount of SRET acceptor.
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Modeling the A2A-CB1-D2 Receptor Heteromer—The quater-
nary structure of the A2A-CB1-D2 heteromer was finally
obtained by combining the CB1-D2 (TM5-TM5 interface) and
CB1-A2A (TM4-TM4invago) models described above (Fig. 8a).
This combination of TM-TM interactions was selected among
the others because it best reproduces the distance betweenGFP
and YFP in the proposed A2A-CB1-D2 receptor heteromer
within the 5.7–6.1-nm range experimentally determined from
FRET efficiencies (see above). Fig. 8b shows a molecular model
of the A2A-CB1-D2 heteromer, in which GFP was fused to
Cys443(CT) of the D2 receptor at the end of the conserved Hx8;
YFP was fused to Leu472(CT) of the CB1 receptor, only four
amino acids apart from the phosphorylated Ser468(CT); and
Thr467(CT)–Ser468(CT) of theCB1 receptor could interact with
Arg205(5.66)–Arg206(5.67) of the A2A receptor. In addition, this
computational model of the A2A-CB1-D2 receptor heteromer
positioned the CT of the A2A receptor toward the D2 receptor
epitope located in the cytoplasm at the end of TM5, so that
phosphorylated Ser374(CT) can interactwith the (5.64) 215VLR-
RRRKRVN224 epitope (Fig. 8, a and c).
As shown above, expression of the CB1A467-A468-YFP or
A2AA374-Rlucmutant receptors leads to a separation of the CT
of CB1 from A2A and the CT of A2A
from D2, respectively. This clearly
suggests that phosphorylated
Thr467(CT)–Ser468(CT) in CB1 or
Ser374(CT) in A2A serves to main-
tain the large and flexible CT of the
receptors in the proper conforma-
tion by interactingwith theArg-rich
epitope of the corresponding pro-
moter. It thus seems reasonable to
suggest that the absence of
Thr467(CT)–Ser468(CT) in CB1 or
Ser374(CT) in A2A modifies the CT
of the mutant receptors, whereas
the packing of the TMs in the A2A-
CB1-D2 heteromer remains similar.
Structure-Function Relationship
in the A2A-CB1-D2 Receptor Het-
eromer—We explored the possibil-
ity that changes in the quaternary
structure of A2A-CB1-D2 receptor
heteromer after disruption of the
electrostatic interactions could cor-
relate with changes in the receptor
heteromer function.We first looked
for differences in signaling (activa-
tion of the MAPK pathway) in cells
co-expressing A2A and D2 receptors
in the absence and presence of CB1
receptors (Fig. 9). In cells co-ex-
pressing A2A and D2 receptors, co-
activation of both receptors with
their respective selective agonists
CGS 21680 (200 nM) and quinpirole
(1 M) produced a similar degree of
ERK1/2 phosphorylation than acti-
vation of either A2A or D2 receptors. As shown in Fig. 9a, the
additional co-expression of CB1 receptor produced a qualita-
tively different pattern with a significantly higher effect of co-
activation of A2A and D2 receptors compared with cells
expressing only A2A and D2 receptors. We then demonstrated
that this pattern of MAPK activation is a biochemical charac-
teristic of the A2A-CB1-D2 receptor heteromer, because it
depends on the integrity of its quaternary structure. In fact, we
found that it particularly depends on the integrity of the intra-
cellular electrostatic interactions that the CB1 receptor forms
with the D2 receptor in A2A-CB1-D2 receptor heteromer. Thus,
in cells expressing CB1A321-A321 or D2S receptors (which lose
the ability to establish electrostatic interactions with the D2 or
the CB1 receptors, respectively, in the A2A-CB1-D2 receptor
heteromer), the pattern of MAPK activation was significantly
altered and qualitatively similar to that observed in cells only
co-expressing A2A and D2 receptors (Fig. 9b).
The pattern of MAPK activation could then be used as a
biochemical fingerprint of theA2A-CB1-D2 receptor heteromer
to detect its presence in the brain (3). In fact, comparing the
pattern of ERK1/2 phosphorylation upon activation of A2A and
D2 receptors in striatal slices from wild-type mice and CB1
FIGURE 8.Molecular model of the A2A-CB1-D2 receptor heteromer. a, schematic model of the heteromer-
ization of A2A (gold), CB1 (red), andD2 (cyan) receptors. Solid lines between TM5 and -6 symbolize IL3 of CB1 (red
line, 29 amino acids long) or D2 (cyan line, 142 amino acids long) receptors, whichwere notmodeled; solid lines
after HX8 represent CT of CB1 (red line) or A2A (gold line), whichwere arbitrarily modeled as in squid rhodopsin;
redspheres representeitherphosphorylatedThr321(IL3)–Ser322(IL3)orThr467(CT)–Ser468(CT)ofCB1orphosphor-
ylated Ser374(CT) of A2A; and blue half-circles represent either Arg
205(5.66)–Arg206(5.67) of A2A or the
215(5.64)VLRRRRKRVN224 or 266NRRRVEAARR275(IL3) epitopes of D2. b, lateral and cytoplasmic views of the
computational model of the A2A-CB1-D2 receptor heteromer. GFP fused to Cys
443(CT) of the D2 receptor (cyan
surface) andYFP fused to Leu472(CT) of theCB1 receptor (red surface) are shown. IL3of CB1 (red line) andD2 (cyan
line) receptors are shown in solid lines to illustrate their proximity. c, cytoplasmic view of the computational
model of theA2A-CB1-D2 receptorheteromer. CTof theCB1 receptor is depicted in the followingmanner: amino
acids Ser414–Asn437 of (red tube ribbon) aremodeled as in the crystal structure of squid rhodopsin, amino acids
Asn437–Asp466 (notmodeled) are shown as a red solid line to illustrate the position of Thr467–Ser468, and amino
acids Ala469–Leu472 (red solid line) are arbitrarily modeled to position YFP. CT of the A2A receptor is depicted in
the followingmanner: amino acids Ser305–Gly328 (golden tube ribbon) aremodeled as in the crystal structure of
squid rhodopsin; amino acids Ser329–Ser412 (notmodeled) are shown as a yellow solid line, and phosphorylated
Ser374 is shown as a red circle. Helices are shown as cylinders with the following color codes: TM4 in gray, TM5
in green, TM6 in blue, and the other helices in yellow for A2A, in red for CB1, and cyan for D2 receptors.
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receptor knock-out mice, we found the same qualitative differ-
ences as those observed in co-transfected cellswith andwithout
CB1 receptors (compare Fig. 8, a and c). Thus, in striatal slices
from CB1 receptor knock-out mice, there was a significantly
lower ERK1/2 phosphorylation upon co-activation of A2A and
D2 receptors compared with that obtained from striatal slices
from wild-type animals. A bifactorial ANOVA demonstrated a
significant genotype effect (p 0.05) and significant treatment/
genotype interaction (p 0.05), and post hoc Bonferroni tests
only showed a significant difference between both groupswhen
the striatal slices were co-treated with CGS 21680 (1 M) and
quinpirole (1 M) (Fig. 9c).
DISCUSSION
This study shows, for the first time, that GPCR heteromers
display emerging properties that depend on their folding
into a certain quaternary structure, determined not only by
interactions between TM domains but also involving inter-
actions between hydrophilic intracellular domains. Signifi-
cantly, we have found that each receptor, A2A, CB1, and D2,
contains two key intracellular domains to interact in a selec-
tive manner with intracellular domains of the other two
receptors by means of electrostatic interactions in the for-
mation of the quaternary structure of the A2A-D2, A2A-CB1,
CB1-D2, and A1-CB1-D2 receptor heteromers. Thus, the D2
receptor contains two Arg-rich epitopes, 215VLRRRR-
KRVN224 and 266NRRRVEAARR275, that interact with poten-
tial CK1/2-dependent phosphorylatable Ser/Thr residues in
CT (Ser374) of the A2A receptor and in IL3 (Thr321–Ser322) of
the CB1 receptor, respectively; CB1 receptor contains adjacent
phosphorylatable Ser and Thr residues in IL3 (Thr321 and
Ser322) and the CT (Thr467 and Ser468) that interact with Arg
residues in IL3 (266NRRRVEAARR275) of the D2 receptor and
Arg205–Arg206 of the A2A receptor, respectively; and the A2A
receptor contains Arg residues at the end of TM5 in the cyto-
plasm at Arg205–Arg206 and a phosphorylatable Ser residue in
the CT (Ser374), which interact with phosphorylatable Ser/Thr
residues in the CB1 receptor CT (Thr467 and Ser468) and an
Arg-rich epitope of the D2 receptor located in the cytoplasm at
the end of TM5 (215VLRRRRKRVN224), respectively. The fact
that each of these three receptors forms electrostatic interac-
tions involving evolutionarily conserved adjacent Arg residues
and CK1/2-dependent phosphorylatable Ser and Thr residues
with the other two receptors suggests that these particular elec-
trostatic interactions constitute a general mechanism for
receptor heteromerization. In studies using synthetic peptides,
it has been shown that these electrostatic interactions are par-
ticularly stable. Thus, theArg-phosphate interaction is so stable
that when using collision-induced dissociation, the noncova-
lent interactions between the Arg guanidinium groups and the
phosphate group remain intact even though the covalent bond
between the serine and phosphate breaks (16, 31–33).
Using bioluminescence resonance energy transfer tech-
niques with mutant receptors, we propose for the first time the
quaternary structure for three interacting GPCRs. Character-
ization of protomer organization within the A1-CB1-D2 recep-
tor heteromer requires, in addition to our findings, integration
of information from a variety of different approaches. Most
compelling are studies that apply disulfide cross-linking tomap
TM interfaces between protomers (10, 12, 13). Modeling of the
CB1-D2, A2A-CB1, and A2A-D2 receptor heterodimers was per-
formed through the entire set of proposed TM interfaces (i.e.
TM1, TM4, or TM5). Our results are compatible with models
proposed for other family A GPCRs, where oligomerization
involves primarily TM4 and TM5 interfaces (Fig. 8). Thus, our
study supports a triangular rather than a linear arrangement of
receptors in the A2A-CB1-D2 heteromer. This arrangement
allows the possibility of simultaneous homodimerization of
FIGURE 9. Agonist-induced ERK1/2 phosphorylation by the A2A-D2-CB1
receptor heteromer. a and b, assays were performed 48 h post-transfection
in cells expressing the indicated receptors (1.2 g of cDNA of the A2A or the
A2A
A205-A206 receptors, 1 g of cDNA of the D2, 0.8 g of cDNA of the D2S
receptor, and 1g of cDNAof the CB1, CB1
A467-A468, or the CB1A321-A322 recep-
tors). Cells were treated for 5 min with 200 nM CGS 21680 (CGS), 1 M quinpi-
role (Quinp), or both (CGS	Quinp) and ERK1/2 phosphorylation was deter-
mined as indicated under “Experimental Procedures.” The immunoreactive
bands from four experiments performed in duplicate were quantified, and
the values represent the mean S.E. of % of phosphorylation relative to the
basal levels found in untreated cells. c, assayswere performed in striatal slices
from wild-type (WT) or CB1 knock-out mice (CB1-KO). The slices were treated
for 10 min with 1 M CGS 21680 (CGS), 1 M quinpirole (quinpirole) or both,
and ERK1/2 phosphorylation was determined as indicated under “Experi-
mental Procedures.” The immunoreactive bands from four to eight slices
obtained from five to nine animals were quantified, and values represent the
mean  S.E. of the % of phosphorylation relative to basal levels found in
untreated slices. Significant differences respect to the wild-type mice were
calculated by bifactorial ANOVA followed by post hoc Bonferroni’s tests (**,
p 0.01; ***, p 0.001).
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each receptor unit using the TM1 interface, which is a well
established phenomenon in the GPCR field. Thus, this study
opens up a new conceptual challenge in the field of receptor
heteromerization, which is the idea that GPCRs can form not
only heteromultimers of three different receptor units but also
higher order heteromultimers or “receptor nets.”
The interactions of the intracellular domains of the CB1
receptor with A2A and D2 receptors were found to be funda-
mental for the correct formation of the quaternary structure
needed for the function of the A2A-CB1-D2 receptor hetero-
mers. Thus, mutant receptors lacking the interacting amino
acids significantly disrupted RET and a specific qualitative pat-
tern of ERK1/2 phosphorylation induced by co-activation of
A2A and D2 receptors. The fact that such a disruption of the
quaternary structure of theA2A-CB1-D2 receptor heteromer (as
demonstrated by SRET experiments) was associated with a sig-
nificant qualitative change in signaling indicates that electro-
static interactions between intracellular domains are also key
determinants for the specific biochemical properties of the
A2A-CB1-D2 receptor heteromer. These biochemical charac-
teristics and the specific qualitative pattern ofMAPK activation
could be used as a biochemical fingerprint of the A2A-CB1-D2
receptor heteromer presence in the brain. CB1 receptor KO
mice experiments provided strong support for the existence of
A2A-CB1-D2 receptor heteromer in the striatum. It has been
hypothesized that A2A-CB1-D2 receptor heteromers aremostly
located in one subtype of striatal neuron, the GABAergic
enkephalinergic neuron, where the three receptors are highly
co-expressed and exert a significant control of basal ganglia
function (34). Most probably, the results obtained with MAPK
signaling are just a minor but the first described example of
many of the potential properties of the A2A-CB1-D2 receptor
heteromers.
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